BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38366706)

  • 1. The association between KRAS and histopathological growth patterns and the impact on resection margins around vasculature and bile ducts in colorectal liver metastases.
    Wong P; Wong GYM; Toon CW; Chapuis P; Hugh TJ
    ANZ J Surg; 2024 Apr; 94(4):560-565. PubMed ID: 38366706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?
    Rhaiem R; Duramé A; Primavesi F; Dorcaratto D; Syn N; Rodríguez ÁH; Dupré A; Piardi T; Fernández GB; Villaverde AP; Rodríguez Sanjuán JC; Santiago RF; Fernández-Moreno MC; Ferret G; Ben SL; Suárez Muñoz MÁ; Perez-Alonso AJ; Koh YX; Jones R; Martín-Pérez E; Kianmanesh R; Di Martino M
    Surgery; 2024 Jul; 176(1):124-133. PubMed ID: 38519408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS Mutation Predicted More Mirometastases and Closer Resection Margins in Patients with Colorectal Cancer Liver Metastases.
    Zhang Q; Peng J; Ye M; Weng W; Tan C; Ni S; Huang D; Sheng W; Wang L
    Ann Surg Oncol; 2020 Apr; 27(4):1164-1173. PubMed ID: 31720935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis.
    Tosi F; Magni E; Amatu A; Mauri G; Bencardino K; Truini M; Veronese S; De Carlis L; Ferrari G; Nichelatti M; Sartore-Bianchi A; Siena S
    Clin Colorectal Cancer; 2017 Sep; 16(3):e153-e163. PubMed ID: 28216246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
    Margonis GA; Buettner S; Andreatos N; Sasaki K; Ijzermans JNM; van Vugt JLA; Pawlik TM; Choti MA; Cameron JL; He J; Wolfgang CL; Weiss MJ
    Ann Surg; 2017 Oct; 266(4):641-649. PubMed ID: 28657938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of resection margin and KRAS status on outcomes after resection of colorectal liver metastases.
    Hatta AAZ; Pathanki AM; Hodson J; Sutcliffe RP; Marudanayagam R; Roberts KJ; Chatzizacharias N; Isaac J; Muiesan P; Taniere P; Mirza DF; Dasari BVM
    HPB (Oxford); 2021 Jan; 23(1):90-98. PubMed ID: 32417170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study.
    Procopio F; Viganò L; Cimino M; Donadon M; Del Fabbro D; Torzilli G
    Eur J Surg Oncol; 2020 May; 46(5):818-824. PubMed ID: 31839435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
    Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
    JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases.
    Sakai N; Furukawa K; Takayashiki T; Kuboki S; Takano S; Ohtsuka M
    BMC Cancer; 2021 Apr; 21(1):412. PubMed ID: 33858364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From bench to bedside: Clinical implications of KRAS status in patients with colorectal liver metastasis.
    Andreatos N; Ronnekleiv-Kelly S; Margonis GA; Sasaki K; Gani F; Amini N; Wilson A; Pawlik TM
    Surg Oncol; 2016 Sep; 25(3):332-8. PubMed ID: 27566041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Implication of KRAS Status after Hepatectomy for Colorectal Liver Metastases Varies According to Primary Colorectal Tumor Location.
    Sasaki K; Margonis GA; Wilson A; Kim Y; Buettner S; Andreatos N; Gani F; Amini N; Spolverato G; Pawlik TM
    Ann Surg Oncol; 2016 Oct; 23(11):3736-3743. PubMed ID: 27352204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of primary cancer features on behaviour of colorectal liver metastases and survival after hepatectomy.
    Cucchetti A; Russolillo N; Johnson P; Tarchi P; Ferrero A; Cucchi M; Serenari M; Ravaioli M; de Manzini N; Cescon M; Ercolani G
    BJS Open; 2019 Apr; 3(2):186-194. PubMed ID: 30957066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of anatomical liver resection on patient survival in KRAS-wild-type colorectal liver metastasis: A multicenter retrospective study.
    Kawai T; Ishii T; Uchida Y; Sato A; Naito S; Kitaguchi K; Komatsubara T; Nakamura I; Ogiso S; Fukumitsu K; Seo S; Fujikawa T; Yasuchika K; Hirose T; Zaima M; Taura K; Hatano E; Terajima H
    Surgery; 2022 Oct; 172(4):1133-1140. PubMed ID: 35965146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients.
    Gholami S; Kemeny NE; Boucher TM; Gönen M; Cercek A; Kingham TP; Balachandran V; Allen P; DeMatteo R; Drebin J; Jarnagin W; D'Angelica M
    Ann Surg; 2020 Aug; 272(2):352-356. PubMed ID: 32675549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ALPPS Approach for Colorectal Liver Metastases: Impact of KRAS Mutation Status in Survival.
    Serenari M; Alvarez FA; Ardiles V; de Santibañes M; Pekolj J; de Santibañes E
    Dig Surg; 2018; 35(4):303-310. PubMed ID: 29032374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases.
    Karagkounis G; Torbenson MS; Daniel HD; Azad NS; Diaz LA; Donehower RC; Hirose K; Ahuja N; Pawlik TM; Choti MA
    Cancer; 2013 Dec; 119(23):4137-44. PubMed ID: 24104864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological growth patterns and positive margins after resection of colorectal liver metastases.
    Nierop PMH; Höppener DJ; van der Stok EP; Galjart B; Buisman FE; Balachandran VP; Jarnagin WR; Kingham TP; Allen PJ; Shia J; Vermeulen PB; Groot Koerkamp B; Grünhagen DJ; Verhoef C; D'Angelica MI
    HPB (Oxford); 2020 Jun; 22(6):911-919. PubMed ID: 31735649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.